Anal Cancer

This is a type of cancer that starts in the anus, the opening at the end of the bottom. It's a serious condition that needs medical treatment. It's important to see a doctor if you notice any changes in the anus.

Condition

What people with Anal Cancer report

Every report comes from a Lived member, sent anonymously.

Have you tried Radiation Therapy for Anal Cancer?

NameHow it went

About Anal Cancer

What It Is

Anal cancer is a cancer that starts in the tissues of the anus, the short opening at the end of the large intestine where stool leaves the body. It is uncommon, accounting for about half a percent of new cancers in the United States, but it has become more frequent over recent decades. Most anal cancers are squamous cell carcinomas, which grow from the flat cells lining the anal canal and the skin just around it. Rarer types, such as adenocarcinoma (which behaves like rectal cancer) and melanoma, are treated differently. Common early signs include bleeding, a lump near the anus, pain or a feeling of fullness, itching or discharge, and changes in bowel habits. Because these symptoms overlap with hemorrhoids and other everyday problems, anal cancer can go unrecognized at first, and some early cancers cause no symptoms at all.

Causes & Risk Factors

Nearly all anal cancers are linked to long-lasting infection with a high-risk type of human papillomavirus (HPV), a very common sexually transmitted virus. Most people clear HPV on their own; cancer develops only when an infection persists for years and gradually changes the lining cells. These changes pass through a precancer stage, called high-grade squamous intraepithelial lesions (HSIL), before becoming invasive cancer. Anything that makes it harder for the body to control HPV raises risk. That includes HIV, especially when the immune system has been weakened, and the immune-suppressing medicines taken after an organ transplant. Receptive anal sex, a larger number of sexual partners, a history of cervical, vaginal or vulvar cancer, and smoking are also associated with higher risk. These factors raise the odds rather than determine an outcome, and many people with anal cancer have none of them beyond a past HPV infection. HPV vaccination protects against the virus types most often responsible and works best when given before any exposure, which is why it is recommended in childhood. Not smoking, and keeping HIV well controlled with treatment, may also lower risk.

How It's Diagnosed

An evaluation usually starts with questions about symptoms and a digital rectal exam, in which a clinician feels the anal canal and lower rectum with a gloved finger. The clinician may then look directly at the area with an anoscope, a short lighted tube, sometimes using magnification (high-resolution anoscopy). A biopsy, a small tissue sample examined under a microscope, is what confirms the diagnosis. Once cancer is found, imaging such as CT, MRI or PET scans shows how large the tumor is and whether it has reached lymph nodes in the groin or pelvis or spread further. Stage is based mainly on tumor size (2 centimeters or smaller, up to 5 centimeters, or larger), lymph node involvement, and spread to distant organs. Tumor size and lymph node status are the two most important factors in outlook. Screening aims to find precancerous changes before cancer develops. Adults with HIV are advised to have anal cancer screening every year, typically starting with a rectal exam and followed by high-resolution anoscopy if anything looks abnormal. In a large trial of people with HIV aged 35 and older, treating HSIL lowered the rate of progression to cancer by more than half compared with monitoring alone. Others at higher risk, such as organ transplant recipients, can ask whether screening suits them.

Treatment Options

For most cancers of the anal canal that have not spread to distant organs, the standard treatment is chemoradiation: radiation to the pelvis usually given on weekdays for five to seven weeks, combined with chemotherapy that makes the radiation more effective. The usual drugs are fluorouracil (5-FU, given as a continuous infusion through a portable pump) or its oral form capecitabine, together with mitomycin. Cisplatin can replace mitomycin for some people. This approach often cures the cancer while keeping the anal sphincter, the muscle ring that controls bowel movements, so most people do not need major surgery or a permanent colostomy. Chemoradiation is demanding. During and shortly after treatment, many people have diarrhea, painful sunburn-like skin in the groin and around the anus, painful bowel movements, fatigue, nausea and low blood counts that raise the risk of infection. Most of these ease over the weeks after treatment ends. Some effects can last or appear later, including bowel urgency or leakage, rectal bleeding from radiation damage, weakened pelvic bones, vaginal narrowing and dryness, erectile problems, and swelling in the legs or genitals. Pelvic radiation can also cause infertility, so people who may want children should ask about sperm banking or egg freezing before treatment starts. Very small tumors in the skin around the anus that do not involve the sphincter can sometimes be removed by surgery alone. A larger operation, abdominoperineal resection, removes the anus and rectum and leaves a permanent colostomy (an opening in the abdomen where stool collects in a bag). It is generally reserved for cancer that remains or returns after chemoradiation. When anal cancer has spread to distant organs, treatment aims to control it and relieve symptoms. Chemotherapy with carboplatin and paclitaxel is a common first choice. In 2025 the FDA approved retifanlimab (Zynyz), an immunotherapy that helps the immune system recognize cancer cells, to be added to that chemotherapy or used on its own after platinum chemotherapy stops working. In its main trial, adding retifanlimab delayed cancer growth by about two months on average. Clinical trials are an important option at this stage. People with HIV generally receive the same treatment with similar results, although those with very low immune cell counts may need adjusted doses.

What to Expect

Anal cancer is usually curable when it is found before it has spread. Most people are diagnosed while the tumor is 5 centimeters or smaller, and in that group more than 85 percent are alive five years later. US figures show five-year relative survival of about 85 percent when the cancer is confined to the anal area, about 70 percent when it has reached nearby tissues or lymph nodes, and about 36 percent when it has spread to distant organs. These averages come from people treated years ago and cannot predict any one person's course. Recovery from chemoradiation takes time. The tumor often continues to shrink for months after treatment ends, so care teams usually wait about six months before judging whether the cancer is fully gone. Follow-up visits with rectal exams, anoscopy and periodic scans typically happen every three to six months for the first few years and less often after that, to check for any remaining or returning cancer and to manage side effects. Life after treatment can involve adjusting to changes in bowel habits, sexual function and comfort, which many people find hard to raise. Pelvic floor therapy, vaginal dilators, dietary changes and medicines can help, as can support from specialist nurses or counseling. People who have had anal cancer also have a higher chance of other HPV-related cancers, such as cervical, vulvar and throat cancers, so routine cancer screenings remain important.

When to Seek Help

See a clinician if you have anal or rectal bleeding, a lump near the anus, ongoing pain or fullness, discharge, or a change in your stools that does not go away. These symptoms are more often caused by hemorrhoids, small tears (fissures) or warts, but they deserve an exam rather than self-treatment, especially when bleeding continues or comes with a lump. During chemoradiation, call your treatment team right away for a fever or other signs of infection, diarrhea you cannot keep up with by drinking, or pain or skin breakdown that stops you from eating, sleeping or using the toilet. After treatment, report new bleeding, a new lump in the anal area or groin, or worsening pain promptly, since these can signal returning cancer or late effects of radiation.

Questions to Ask Your Doctor

  1. 1.What type and stage of anal cancer do I have, and what does that mean for my chances of cure?
  2. 2.Is chemoradiation the right approach for me, and how likely is it that I can avoid surgery and a colostomy?
  3. 3.Which short-term and long-term side effects should I prepare for, and what can be done to prevent or ease them?
  4. 4.Should I take steps to protect my fertility or sexual function before treatment begins?
  5. 5.How will we know whether the treatment worked, and what will follow-up look like over the next few years?

Last reviewed • Oct 2026

Educational content, not medical advice.